CBIO
Crescent Biopharma, Inc.
14.90$
+5.6%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | – | – | – | – | – | 100.0% | – | – | – | – | – | – | 100.0% | 100.0% | 100.0% | – | 100.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 150.2% | – | – | – | 1,450.9% | – | 344.6% | – | – | – | – | – | 233.0% | – | – | – | – | – | – | 5.3% | 0.5% | – | – | – | |
| 100.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | – | – | – | – | – | 100.0% | – | – | – | – | – | – | 94.7% | 100.0% | 100.0% | – | – | |
| 32,007.9% | – | – | – | – | – | – | – | – | – | – | – | – | – | 140.8% | – | 1,067.0% | 7,193.3% | 1,056.2% | 7,160,057.7% | 15,343.8% | 73,165.9% | – | 10,631.0% | – | – | – | – | – | 52,884.5% | – | – | – | – | – | – | 66.6% | 876.3% | 1,723.1% | – | 359.7% | |
| 10,724.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | 49.3% | – | 405.8% | 2,461.7% | 396.8% | 2,983,802.8% | 4,785.1% | 25,806.6% | – | 7,273.3% | – | – | – | – | – | 43,120.0% | – | – | – | – | – | – | 18.1% | 67.4% | 757.0% | – | 69.4% | |
| 42,731.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | 190.1% | – | 1,472.7% | 9,654.9% | 1,453.0% | 10,144,101.4% | 20,128.8% | 98,970.2% | – | 17,904.2% | – | – | – | – | – | 96,008.3% | – | – | – | – | – | – | 84.7% | 943.7% | 2,480.1% | – | 424.9% | |
| -42,631.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | -90.1% | – | -1,372.7% | -9,554.9% | -1,353.0% | -10,144,001.4% | -20,028.8% | -98,870.2% | – | -17,804.2% | – | – | – | – | – | -95,908.3% | – | – | – | – | – | – | -84.7% | -843.7% | -2,380.1% | – | -396.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.0% | 30.0% | 0.0% | – | 7.7% | |
| -42,458.9% | – | – | – | – | – | – | – | – | – | – | – | – | – | -85.1% | – | -1,372.3% | -9,551.5% | -1,352.4% | -10,140,083.8% | -20,023.5% | -98,849.4% | – | -17,690.3% | – | – | – | – | – | -90,782.6% | – | – | – | – | – | – | -80.5% | -833.6% | -2,240.9% | – | -384.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 18.4% | – | – | – | |
| -42,457.8% | – | – | – | – | – | – | – | – | – | – | – | – | – | -85.1% | – | -1,372.3% | -9,551.5% | -1,352.4% | -10,140,324.6% | -20,023.5% | -98,847.1% | – | -17,690.1% | – | – | – | – | – | -90,786.4% | – | – | – | – | – | – | -80.5% | -852.1% | -2,240.9% | – | -384.0% | |
| -42,384.6% | – | – | – | – | – | – | – | – | – | – | – | – | – | -89.3% | – | -1,366.1% | -9,513.0% | -1,346.5% | -10,096,235.9% | -19,951.0% | -98,522.7% | – | -17,731.3% | – | – | – | – | – | -95,671.6% | – | – | – | – | – | – | -80.4% | -833.1% | -2,234.7% | – | -383.8% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.